Bibliotecas PUC-SP - Busca Integrada

Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties

Por Geoffrey D. Wool, Catherine A. Reardon, Godfrey S. Getz
Publicado no Journal of Lipid Research (2008-06-01)

Mimetic peptides of human apoA-I helix 10 get together to lower lipids and ameliorate atherosclerosis: is the action in the gut?1

Por Geoffrey D. Wool, Catherine A. Reardon, Godfrey S. Getz
Publicado no Journal of Lipid Research (2014-10-01)

Editorial: The immunological role of platelet activation in the pathophysiology of COVID-19

Por Theresa Marie Rossouw, Etheresia Pretorius, Etheresia Pretorius, Geoffrey D. Wool
Publicado no Frontiers in Immunology (2023-09-01)

An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide

Por Geoffrey D. Wool, Tomas Vaisar, Catherine A. Reardon, Godfrey S. Getz
Publicado no Journal of Lipid Research (2009-09-01)

(More than) doubling down: Effective fibrinolysis at a reduced rt-PA dose for catheter-directed thrombolysis combined with histotripsy.

Por Samuel A Hendley, Aarushi Bhargava, Christy K Holland, Geoffrey D Wool, Osman Ahmed, Jonathan D Paul, Kenneth B Bader
Publicado no PLoS ONE (2022-01-01)

(More than) doubling down: Effective fibrinolysis at a reduced rt-PA dose for catheter-directed thrombolysis combined with histotripsy

Por Samuel A. Hendley, Aarushi Bhargava, Christy K. Holland, Geoffrey D. Wool, Osman Ahmed, Jonathan D. Paul, Kenneth B. Bader
Publicado no PLoS ONE (2022-01-01)

Assessment of histological characteristics, imaging markers, and rt-PA susceptibility of ex vivo venous thrombi

Por Samuel A. Hendley, Alexey Dimov, Aarushi Bhargava, Erin Snoddy, Daniel Mansour, Rana O. Afifi, Geoffrey D. Wool, Yuanyuan Zha, Steffen Sammet, Zheng Feng Lu, Osman Ahmed, Jonathan D. Paul, Kenneth B. Bader
Publicado no Scientific Reports (2021-11-01)

Clinical and molecular response of acute myeloid leukemia harboring non-canonical <i>FLT3</i> N676K driver mutations to contemporary FLT3 inhibitors

Por Gregory W. Roloff, Frank Wen, Aubrianna Ramsland, Andrew S. Artz, Satyajit Kosuri, Wendy Stock, Olatoyosi Odenike, Richard A. Larson, Hongtao Liu, Lucy A. Godley, Michael J. Thirman, Anand A. Patel, Christopher K. Daugherty, Adam S. DuVall, Mariam T. Nawas, Emily Dworkin, Geoffrey D. Wool, Sandeep Gurbuxani, Carrie Fitzpatrick, Jeremy P. Segal, Peng Wang, Michael W. Drazer
Publicado no Haematologica (2023-01-01)